“You have cirrhosis” and “you need a transplant” are two very different statements, yet many patients and families understandably hear them as one and the same when a diagnosis is first made.In reality, most people with cirrhosis do not require an immediate liver transplant. Many live for years, sometimes decades, with good quality of life through careful medical treatment, regular surveillance, and timely management of complications.

The question that matters is not whether someone has cirrhosis, but whether their liver has reached the point where transplantation offers a better chance of long-term survival and quality of life than continued medical therapy.

This guide explains where that clinical threshold lies, the warning signs that suggest the liver is beginning to fail, how transplant specialists make this decision, and why early referral for transplant assessment can make a significant difference to outcomes.

One of the commonest misconceptions Dr. Manikandan Kathirvel encounters in clinical practice is that a liver transplant is only considered when a patient is critically ill or has no other option. In fact, the opposite is often true.

The best transplant outcomes are usually achieved when patients are referred soon after the first episode of liver decompensation, such as the development of ascites, variceal bleeding, hepatic encephalopathy, or jaundice, rather than after multiple complications have occurred.

Families are often reassured because the patient still looks reasonably well, is able to walk, eat, and carry out daily activities, and therefore assume that transplantation can safely be postponed. Unfortunately, cirrhosis does not always progress gradually. Many patients remain stable for prolonged periods before deteriorating rapidly over weeks or months.

Dr. Manikandan Kathirvel frequently explains to patients that referral for transplant assessment is not the same as being listed for transplantation. Early assessment allows the team to optimise nutrition, complete a comprehensive evaluation, identify suitable living or deceased donor options where appropriate, treat reversible problems, and prepare the patient while they are still in the best possible condition for surgery.

Waiting until the liver has failed completely often limits treatment options and significantly increases the risks associated with transplantation.

In his practice, Dr. Manikandan Kathirvel would always rather assess a patient earlier and conclude that a transplant is not yet required than see them referred too late, when opportunities to achieve the best outcome have already been lost.

Key Takeaways

• Cirrhosis itself is not the trigger for a transplant. The trigger is decompensation: the point where the liver can no longer keep up with the body’s needs.
• The first decompensation event (ascites, variceal bleeding, jaundice, or confusion from hepatic encephalopathy) is a turning point in prognosis, not just a symptom to treat and move past.
• Two scoring systems, MELD and Child-Pugh, are used together to judge severity and transplant urgency; neither replaces a surgeon’s direct clinical judgment.
• A patient can look relatively well and still be in genuine danger; equally, a patient with alarming symptoms is not automatically a transplant candidate without full evaluation.
• Earlier referral for surgical evaluation, even before a family is sure a transplant is needed, generally leads to better outcomes than waiting for a crisis.

Cirrhosis Has Two Phases, and Only One Is Urgent

Cirrhosis develops in two broad phases, and the difference between them is the most important distinction in this guide.

Compensated cirrhosis is the earlier phase. Scarring is present, but the liver still manages to do its job. Many patients have no symptoms, or only mild ones, and can live with compensated cirrhosis for years. Five-year survival in this phase is generally good, which is why it does not call for transplant evaluation on its own.

Decompensated cirrhosis is the later phase, and it changes everything. This is the point where scarring has progressed enough that the liver and the portal venous system around it can no longer manage normal demands. Much of what goes wrong at this stage traces back to portal hypertension: as scar tissue obstructs blood flow through the liver, pressure builds in the portal venous system, and the body’s compensatory responses, including fluid retention and the dilation of blood vessels elsewhere, eventually produce the visible complications below. The shift is not subtle once it happens; it typically announces itself through a specific event, not a gradual decline a patient notices alone.

The Decompensation Events That Change the Conversation

Decompensation is defined by the appearance of one or more of these complications:

• Ascites: fluid accumulating in the abdomen, causing swelling and discomfort, usually the first decompensating event a patient experiences. Initial management is sodium restriction and diuretics, but ascites that no longer respond to high-dose diuretics, known as refractory ascites, is itself a strong signal that transplant evaluation should not be delayed further.
• Variceal bleeding: bleeding from enlarged, fragile veins in the food pipe or stomach from pressure backing up through the portal venous system. Can present as vomiting blood or black, tarry stools, and is a medical emergency.
• Hepatic encephalopathy: confusion, drowsiness, or personality change from toxins the liver can no longer clear. Often mistaken for tiredness or unrelated memory issues.
• Jaundice: yellowing of the skin and eyes, reflecting the liver’s declining ability to process bilirubin.
• Hepatorenal syndrome: a decline in kidney function that develops as a direct consequence of advanced liver disease, not a separate kidney problem.

Any one of these, occurring for the first time in a patient with known cirrhosis, is what surgeons mean by “decompensated.” It is this moment, not the original cirrhosis diagnosis, that should prompt a referral for transplant evaluation.

For a full explanation of how the MELD score determines transplant urgency and how TRANSTAN manages deceased donor allocation in Tamil Nadu, see [Liver Transplant in Chennai: The Complete Patient Guide].

How Severity Is Measured: MELD and Child-Pugh

Two scoring systems are used, often together, to judge disease severity and transplant urgency.

The MELD score (Model for End-Stage Liver Disease) is calculated from bilirubin, creatinine, and INR, producing a number from 6 to 40, and is the primary score used to rank patients for deceased donor allocation in India, including through Tamil Nadu’s TRANSTAN system. It is explained in full in Liver Transplant in Chennai: The Complete Patient Guide, and in a dedicated post on what the MELD score means and how it decides transplant priority in India.

The Child-Pugh score, the older of the two systems, is still used alongside MELD because it captures five parameters MELD does not directly measure: the presence and severity of ascites, the grade of hepatic encephalopathy, serum albumin, bilirubin, and prothrombin time — classifying patients into Class A, B, or C based on their combined score. It classifies patients into Class A, B, or C, with C the most advanced. A patient who has just decompensated for the first time typically sits at late Class B or into Class C.

Neither score alone tells the full story. Functional status, nutrition, frailty, and response to initial treatment all factor into a surgeon’s recommendation, which is why the same MELD score in two patients can lead to two different conversations about timing.

Why “Wait and See” Is the Wrong Instinct

A common family response to a first episode of ascites or bleeding is relief once the acute episode is treated, followed by a return to normal life. This is, more often than not, a mistake.

The first decompensation event marks the disease entering a different phase, not an isolated incident to be treated and forgotten. Research on the natural history of cirrhosis (D’Amico et al., Journal of Hepatology, 2006) shows median survival falling from roughly 10 to 15 years in compensated cirrhosis to around 1 to 2 years after the first decompensating event, and a second decompensation tends to arrive with less warning and higher mortality than the first. This is why surgeons recommend evaluation at first decompensation, not after a second or third episode.

This does not mean every patient who decompensates is on an irreversible path. If the underlying cause can be controlled, certain viral infections, or alcohol use that genuinely stops, some patients experience what is sometimes called recompensation, where liver function partially recovers and the urgency of transplant eases. This possibility is precisely why an early, thorough evaluation matters: it identifies which patients may respond to treatment of the underlying cause and which need to proceed toward transplant without delay, rather than leaving that distinction to be discovered later under worse circumstances.

What a Transplant Evaluation at This Stage Looks Like

Being referred for evaluation does not mean a transplant is certain, or even likely soon. It means a surgeon can now track the patient’s trajectory before a crisis forces a faster decision.

A typical evaluation includes confirming MELD and Child-Pugh scores, identifying the underlying cause of cirrhosis, screening for liver cancer with imaging and blood markers, and assessing cardiac and pulmonary fitness for major surgery. Nutritional status is checked as well, since muscle wasting is common in advanced liver disease and can affect how a patient tolerates surgery and recovers afterward. For many patients, this also opens the conversation about whether a living donor transplant is feasible within the family, alongside possible TRANSTAN registration for a deceased donor liver. None of this needs to happen in a single visit; it is a process that typically unfolds over several appointments as results come in.

The Bottom Line for Families

If a family member with cirrhosis has just experienced their first episode of ascites, variceal bleeding, hepatic encephalopathy (confusion), or jaundice, that should be viewed as an important turning point—not simply another complication to be treated before returning to routine follow-up. While not every patient who develops a first decompensation will require an immediate liver transplant, every such patient should undergo a timely transplant assessment to determine whether they are approaching the stage at which transplantation offers the best long-term outcome. Early referral provides time to optimise nutrition, improve physical fitness, complete a comprehensive transplant work-up, treat reversible medical problems, and, if appropriate, evaluate potential living donors without the pressure of an emergency. It also allows patients and families to understand the transplant process before they are faced with a life-threatening deterioration.

In Dr. Manikandan Kathirvel’s practice, the ideal time to involve a transplant surgeon is after the first episode of liver decompensation, not after repeated hospital admissions. He frequently sees patients referred only after they have developed recurrent ascites, multiple episodes of variceal bleeding, repeated hepatic encephalopathy, progressive jaundice, or worsening kidney dysfunction. By then, they are often significantly malnourished, physically deconditioned, and may have developed infections or other complications that increase the risks of transplantation.

A common misconception is that transplant referral should wait until the physician has “run out of options.” In reality, transplant assessment should run alongside ongoing medical management, not after it has failed. Many patients assessed early ultimately do not require an immediate transplant, and they continue under careful surveillance until the timing is right. Others benefit from being listed before a further decompensation occurs or from having sufficient time to evaluate a suitable living donor. The greatest advantage of early referral is that it allows decisions to be made in a controlled, planned setting rather than during a medical emergency. In liver transplantation, timing is one of the few factors that can be influenced, and timely referral consistently gives patients the greatest opportunity for the safest surgery and the best long-term outcomes.

If a First Decompensation Event Has Just Happened

If a family member with cirrhosis has just had their first episode of ascites, bleeding, jaundice, or confusion, that is the right moment to ask whether a surgical evaluation is needed, not a moment to wait through. Dr. Manikandan Kathirvel sees patients for liver transplant evaluation at Gleneagles Hospital, Chennai. Evaluation can be requested directly; no prior referral is required. You can request an evaluation.